SB

Samsara BioCapital Portfolio holdings

AUM $489M
This Quarter Return
+5.61%
1 Year Return
+135.25%
3 Year Return
+909.96%
5 Year Return
+774.56%
10 Year Return
–
AUM
$489M
AUM Growth
+$489M
Cap. Flow
-$42.5M
Cap. Flow %
-8.69%
Top 10 Hldgs %
88.2%
Holding
39
New
2
Increased
1
Reduced
9
Closed
10

Top Buys

1
AURA icon
Aura Biosciences
AURA
$6.26M
2
JBIO
Jade Biosciences, Inc. Common Stock
JBIO
$5.31M
3
ALMS
Alumis Inc. Common Stock
ALMS
$4.6M

Top Sells

1
PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
$7.66M
2
UPB
Upstream Bio, Inc. Common Stock
UPB
$6.85M
3
SLRN
ACELYRIN
SLRN
$6.23M
4
BOLT icon
Bolt Biotherapeutics
BOLT
$5.75M
5
RYTM icon
Rhythm Pharmaceuticals
RYTM
$5.54M

Sector Composition

1 Healthcare 99.99%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ARTV
26
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$74.8M
$440K 0.09%
291,666
– –
BOLT icon
27
Bolt Biotherapeutics
BOLT
$9.29M
$303K 0.06%
52,456
-996,697
-95% -$5.75M
NUVB.WS icon
28
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$66.5M
$36K 0.01%
133,333
– –
SRZNW icon
29
Surrozen, Inc. Warrant
SRZNW
$71.9K
$1.81K ﹤0.01%
99,999
– –
ABVX
30
Abivax
ABVX
$6.26B
– –
-425,000
Closed -$2.66M
ALLK
31
DELISTED
Allakos
ALLK
– –
-172,089
Closed -$39.2K
CRIS icon
32
Curis
CRIS
$21.4M
– –
-185,943
Closed -$390K
INZY
33
DELISTED
Inozyme Pharma
INZY
– –
-1,562,500
Closed -$1.42M
KRON
34
DELISTED
Kronos Bio
KRON
– –
-78,131
Closed -$64.5K
LPTX icon
35
Leap Therapeutics
LPTX
$12.2M
– –
-2,442,352
Closed -$745K
LYRA icon
36
Lyra Therapeutics
LYRA
$11.8M
– –
-1,390,130
Closed -$176K
PRME icon
37
Prime Medicine
PRME
$594M
– –
-405,228
Closed -$806K
SLRN
38
DELISTED
ACELYRIN
SLRN
– –
-2,523,022
Closed -$6.23M
OKUR
39
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$38.7M
– –
-824,155
Closed -$3.54M
1
2